All Posts
All Behind the Spec
News Article

Clarivate.com | Atonarp takes aim at molecular diagnostics with automated, AI-driven, point-of-care tech

Published on
August 30, 2019
Subscribe to newsletter
By subscribing you agree to with our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Tokyo-based Atonarp Inc. has a very clear mission, to develop automated, AI-based, miniaturized platforms for mass spectrometry and optical spectroscopy. But that sort of complex molecular analysis has a wide range of potential industry applications, making it difficult to prioritize efforts.

The startup company has already commercialized the first quantitative, real-time miniaturized mass spectrometers for semiconductor and pharmaceutical industry gas detection. Its first product is geared toward monitoring pharmaceutical lyophilization, which is a freeze-drying process commonly used by the pharmaceutical industry for product stabilization, for contamination, leaks or other problems.